Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyotrophic lateral sclerosis.

J D Mitchell1, G D Borasio2

  • 1Motor Neurone Disease Care and Research Centre, Royal Preston Hospital, Fulwood, Preston PR2 9HT, UK.

Lancet (London, England)
|June 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiation Oncology Opinions and Practice on Cardiotoxicity in Lung Cancer: A Cross-sectional Study by the International Cardio-oncology Society.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Implementation of the ID-PALL Assessment Tool for Palliative Care Needs: A Feasibility and Prevalence Study in a Tertiary Hospital.

Palliative medicine reports·2024
Same author

A Case of Hypertrophy of the Left Ventricle, Complicated with Pleurisy, &c.: Paracentisis Thoracis.

Western journal of medicine and surgery·2024
Same author

Risk profiles and incidence of cardiovascular events across different cancer types.

ESMO open·2023
Same author

Clark County Medical Society.

Chicago medical examiner·2023
Same author

Clark County Medical Society.

Chicago medical examiner·2023
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
See all related articles

Amyotrophic lateral sclerosis (ALS), or motor neuron disease, is a complex neurological disorder. This review covers ALS natural history, causes, treatments, symptom management, and future research directions like stem-cell therapy.

Area of Science:

  • Neurology
  • Neuroscience

Background:

  • Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, presents complex challenges in understanding its pathogenesis.
  • The condition affects individuals globally, necessitating comprehensive reviews of its multifaceted aspects.

Purpose of the Study:

  • To provide a comprehensive overview of amyotrophic lateral sclerosis (ALS).
  • To discuss current knowledge on ALS natural history, clinical features, diagnostics, genetics, and epidemiology.
  • To explore potential causes, treatments, symptom management, and future research avenues for ALS.

Main Methods:

  • Literature review of amyotrophic lateral sclerosis (ALS).
  • Synthesis of information on ALS natural history, clinical presentation, diagnostic criteria, and epidemiology.

Related Experiment Videos

  • Discussion of etiological hypotheses, therapeutic strategies, and disease management.

    • Main Results:

    • ALS is characterized by uncertain pathogenesis, with hypotheses including excitotoxicity and oxidant stress.
    • Management strategies encompass symptom control (dysphagia, dysarthria, respiratory distress, pain, psychological disorders) and palliative care.
    • Future prospects include disease markers, stem-cell, and gene therapy for ALS.

    Conclusions:

    • Effective management of ALS requires addressing physical, psychological, and spiritual needs of patients and families.
    • Ongoing research into disease markers and novel therapies like stem-cell and gene therapy holds promise for ALS.
    • A multidisciplinary approach is crucial for optimizing care and outcomes in amyotrophic lateral sclerosis (ALS).